1 completed, 1 unknown, 1 withdrawn. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Unknown 1, Withdrawn 1 |
Follow ThermoDox: new trials by email Literature Review of ThermoDox trials Research Report on ThermoDox
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PanDox: Targeted Doxorubicin in Pancreatic Tumours Focused Ultrasound, Doxorubicin, ThermoDox - Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV | Phase 1 | Withdrawn | University of Oxford | 2021-06-16 | 2023-04-12 | |
| Image-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast Cancer LTLD, MR-HIFU induced hyperthermia, Cyclophosphamide - Metastatic Breast Cancer, Breast Cancer | Phase 1 | Unknown | UMC Utrecht | 12 | 2021-03-01 | 2021-02-17 |
| A Study of ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver ThermoDox - Hepatocellular Carcinoma, Liver Neoplasms | Phase 1 | Completed | Imunon | 30 | 2007-02-01 | 2019-02-07 |
Hyperthermia (2) · Breast Neoplasms (1) · Carcinoma, Ductal, Breast (1) · Carcinoma, Hepatocellular (1) · Liver Neoplasms (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Pancreatic Neoplasms (1)
Imunon (1) · UMC Utrecht (1) · University of Oxford (1)
Netherlands (1) · United Kingdom (1) · United States (1)
Britt BM Suelmann, MD (1) · Mark Middleton (1)
2015 (1)